Adult pneumococcal vaccination – new opportunities

Abstract

disease in adults and the vaccines used for prophylaxis for pneumococcal infection. the article discusses the pneumococcal infection burden in the adult population and the factors that raise the risk of infections. we characterised available vaccines for adults, highlighting the significant differences between the conjugated and unconjugated polysaccharide vaccines. Current epidemiological data on pneumococcal infections in europe and poland is presented. the latest 20-valent pneumococcal conjugate vaccine (pCV20) is described, and the most recent advisory Committee on immunization practices (aCip) recommendations on primary prevention and the current implementation of vaccination against pneumococcal infections in the adult population in poland are discussed.